Views: 0 Author: Site Editor Publish Time: 2026-10-07 Origin: Site
Formula, foamer pump and final bottle must be reviewed together: Treat them as one project system; a good bulk liquid cannot prove finished-pack performance.
Four dispensing states reveal output drift: Compare the first dispense after priming, normal repeated strokes, post-storage recovery and near-end-of-pack behavior. One demonstration is not enough.
Foam volume and foam persistence are two different measurements: Measure foam mass/volume behavior and foam decay separately. A large foam volume is not automatically a dense or persistent consumer experience.
Five sample checkpoints should be approved before production: Review initial output, repeatability, foam structure, stored-sample recovery and pack integrity before the formula is released for production.
A nine-item release record protects scale-up: Retain the formula, pump, bottle, output method, foam method, sample conditions, results, exceptions and approval decision before mass production.
Protocol note: The 3-element review, 4 dispensing states, 5 checkpoints and 9-item release record below are an OEM project template—not universal product specifications, regulatory requirements or release standards. Tailor them to the formula, final pack and target-market requirements.
A foam mouthwash project is a dispensing system, not a liquid formula poured into a foam bottle. The foam depends on formula behavior, pump architecture and bottle/component fit.
This page starts after a brand has chosen foam as its format. For the commercial choice between foam and liquid, including logistics and product-line positioning, see Qiaoerna’s Foam Mouthwash vs Liquid Mouthwash comparison.
System element | Buyer decision | What the OEM should test with the real sample |
|---|---|---|
Formula | What liquid behavior is intended before it enters the pump? | Appearance, pH route, rheology method and storage observations. |
Foamer pump | What is intended for one action? | Prime condition, delivered mass/volume, recovery and mesh/valve observations. |
Final pack | Will components preserve that behavior? | Compatibility, closure observations, storage recovery and near-end output. |
The approval question is: “Does this formula and pump create the agreed foam profile under stated conditions?”
Foam inconsistency can affect first-use and repeat-use experience. Repeated priming, a watery burst, uneven foam or poor recovery after storage can change the intended experience.
A technical release plan separates four different consumer-facing failure modes:
Insufficient foam: output looks wet or collapses too early.
Over-expanded/dry foam: apparent volume is high but feel or spread is wrong.
Output variation: one stroke differs from another.
Stored-pack change: performance changes after a defined exposure.
A 2024 formulation study treated volume, stability, density, texture and actuation force as separate variables—not “more foam” as one pass/fail answer.[1] The sample brief should therefore separate output, foam character, and post-storage recovery.
A tall foam is not automatically the right foam. Density, bubble structure, wetness and decay can move differently. Approve a repeatable sensory and placement profile, not a one-off visual.
A published foam-mouthwash study describes a commercial pump product with bubble sizes of 0.05–0.5 mm. That is useful proof that bubble structure can be described, but it is not a universal bubble-size target for a new formula.[2]
Check | How to make it repeatable | Why the buyer should care |
|---|---|---|
Foam quantity | Use a defined vessel, action and reading time. | Avoids comparing differently primed strokes. |
Foam density | Record foam mass relative to volume under the same method. | Distinguishes airy from compact output. |
Bubble structure | Record a visual observation at the same time point. | Makes “fine,” “coarse,” “wet,” or “dry” an agreed observation. |
Foam decay | Record retained foam or drainage at stated times. | Separates initial volume from later behavior. |
Do not approve “dense foam” as a sentence alone. Put container, pump stroke, prime state, sample temperature, observation time and pass/fail description on the sheet. A QbD foam study used 3 repeated measurements; that is a useful starting point for method agreement, not a universal rule.[1]
“One pump” is not a specification until its prime state, stroke, output method and test conditions are written down. A foamer can differ at first actuation, after repeated use, after storage, or near the end of fill.
Use the following 4-state test map in the development protocol:
Pump state | What to record | Decision it informs |
|---|---|---|
1. Initial prime | Preparation strokes, first foam output and liquid-only discharge. | First-use behavior. |
2. Repeated dispensing | Delivered mass/volume and foam profile across complete strokes. | Normal-use consistency. |
3. Post-storage recovery | Prime/recovery, output and foam after defined exposure. | Return to agreed delivery behavior. |
4. Near-end-of-pack | Output and air-intake/sputtering observations near fill limit. | Usability through intended fill range. |
Packaging guidance likewise treats formula, bottle and pump as one system and reviews priming, recovery, output, leakage, mesh, seals and repeated actuation.[3] It is guidance, not an oral-care standard; a water-like proxy cannot approve the pump.
Test the actual formula through the actual pump, not a low-viscosity substitute. Surfactants, solubilized flavor, modifiers, suspended material and temperature can alter mesh/pump delivery. If formula, supplier, pump, mesh, dip tube, fill level or bottle changes, identify which of the 4 states must be repeated.
A clear bulk formula does not prove a stable foam-mouthwash SKU. The formula must still create the agreed output and foam after pump, bottle, closure and storage contact.
A mouthwash comparison followed foam behavior for 20 minutes and used drainage half-life plus retained height to distinguish stability mechanisms.[4] Its time window is a method example, not a mandatory consumer or release requirement.
Stability layer | What can change | What to evaluate |
|---|---|---|
Bulk formula | Appearance, phase behavior, pH or rheology. | Record method and condition; do not rely on one visual check. |
Foam behavior | Volume, wetness, drainage, bubble growth or collapse. | Compare the agreed method at stated checkpoints. |
Pump and pack | Prime, recovery, output, mesh/valve, closure or component change. | Use real formula in representative components. |
Microbiological control | Water/raw materials, manufacture, preservation, pack or storage. | Use the appropriate quality route; do not infer safety from foam appearance. |
FDA identifies raw materials/water, manufacturing, preservation, packaging and storage as potential cosmetic contamination routes.[5] This general principle supports connected formula, pump, bottle and storage review; it does not classify a particular mouthwash. Applicable quality and regulatory requirements depend on product claims and target market.
Do not approve a stability observation without a dispensing check. After each agreed exposure, repeat selected output and foam observations; record prime requirement, foam balance, output and closure behavior.
A short, controlled checkpoint plan is more useful than a vague test list. Agree the method before comparing samples and show formula/pack revision on every record.
Checkpoint | What is reviewed | Minimum record to retain |
|---|---|---|
1. Formula identification | Formula revision and intended foam brief. | Revision code, date and target description. |
2. Initial foam check | Defined action, foam quantity/density and structure. | Pump state, condition, method and result. |
3. Output repeatability | Complete strokes in the agreed state. | Raw observations and decision. |
4. Stored-sample recovery | Output, foam and visible pack condition after exposure. | Exposure, recovery observations and result. |
5. Final-pack approval | Representative bottle, pump, closure and fill condition. | Component identifiers, exceptions and sign-off. |
These 5 checkpoints are an OEM project framework, not legal or clinical standards.
A suitable manufacturer shows a controlled method, not only a dense demonstration sample. For this project template, retain this 9-item release record before scale-up:
Formula and sample revision code.
Supplier/material-change status relevant to the tested formula.
Bottle, pump, dip-tube and closure identifiers.
Fill condition used for the sample.
Defined prime state and dispensing action.
Output measurement method and raw observations.
Foam-density/structure and decay observation method.
Storage or compatibility conditions and post-storage result.
Exceptions, changes, approval decision and re-test responsibility.
For Qiaoerna’s relevant product route, see the Mouthwash OEM category. Start with intended foam experience and pack architecture, then build an auditable sample plan.
It is a repeatable observation from the chosen formula and pump: measured foam mass/volume plus structure and decay under stated conditions. It is not a universal “more is better” target. State vessel, pump state, dispense action, temperature and reading time.
Use the actual formula, selected pump and representative bottle. In the project protocol, define prime state and dispensing action, then record delivered mass/volume and foam behavior across 4 states: initial prime, repeated dispensing, post-storage recovery and near-end-of-pack output.
A formula can be developed before final component selection, but final delivery approval needs a representative pump and bottle. Complete output and foam checks after the delivery system is identified.
Include formula revision, component identifiers, fill condition, priming, output and foam methods/results, storage observations, visible component observations, exceptions and approval decision.
MOQ depends on formula route, pump sourcing, bottle decoration, component availability, verification scope and production schedule. Request a SKU-specific quotation separating sampling, components, verification, production and release.
Potentially. Confirm whether a change affects foam density, output, priming, recovery or pack compatibility, then repeat the relevant checkpoint.
Timing depends on formula, pump/bottle availability, artwork, sample iterations and verification. Request a plan separating formula sample, component sample, final-pack checks, approval and production.
Validate the Foam System Before You Approve the SKU. Share your intended foam experience, target market, formula direction, pump/bottle preference, fill concept and launch window. Qiaoerna can turn them into a formula-and-pack sample plan with defined output, foam and stability checks. Contact admin@qiaoerna.com.cn or use the Qiaoerna contact page.
Author: Xiaoying, Head of R&D, Qiaoerna Biotechnology Co., Ltd.
Technical Review: Qiaoerna Quality & Compliance Team — formula, foamer-pump, packaging-fit and technical sample-control review.
Bogdan, C., et al. (2024). QbD Approach in Cosmetic Cleansers Research: The Development of a Moisturizing Cleansing Foam Focusing on Thickener, Surfactants and Polyols Content. Gels, 10(8), 484. DOI: 10.3390/gels10080484.
Key finding: The skin-cleansing foam study treats foam volume, stability, density, texture and actuation force as separate response variables and uses repeated measurement. It supports a measurement framework only; it is not an oral formula or acceptance-limit source.
Jones, S. B., et al. (2018). The antibacterial efficacy of a foam mouthwash and its ability to remove biofilms. BDJ Open, 4, 17038. PMCID: PMC6160478. DOI: 10.1038/s41405-018-0005-5.
Key finding: The study describes a foam-pump mouthwash product and reports a product-context bubble-size range. It does not establish a universal bubble target, manufacturing specification or finished-product claim.
APACKAGING GROUP. (n.d.). How do you test a foamer pump with a cosmetic formula? Source.
Key finding: Packaging-industry guidance recommends testing formula, bottle and pump together across priming, output, recovery, mesh, seals, repeated actuation and temperature conditions. It is not a regulatory standard.
Centre for Industrial Rheology. (n.d.). Foaming at the Mouth – Comparing Foaming Behaviour of Mouthwash Formulations. Source.
Key finding: Foamability, drainage half-life, retained height and bubble-size distribution can distinguish foam formation from foam decay. Its comparative 20-minute laboratory observation is a method example, not a mandatory requirement.
U.S. Food and Drug Administration. (2024). Microbiological Safety and Cosmetics. Content current 15 October 2024. FDA.
Regulatory basis: FDA identifies raw materials/water, manufacturing, preservation, protective packaging and storage as relevant microbiological-safety factors and states that manufacturers/distributors are responsible for product safety. The source does not classify a particular foam-mouthwash project.

